US 10301365
Met e 1 tropomyosin variants for use in allergen-specific immunotherapy
granted A61KA61K38/00A61K38/1709
Quick answer
US patent 10301365 (Met e 1 tropomyosin variants for use in allergen-specific immunotherapy) held by The Regents of the University of California expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K9/0019, A61K9/0053